Sp03
CURRENT THERAPIES PRIMARY LANGERHANS CELL HYSTIOCYTOSIS
Deniz Tuğcu
Istanbul University, Istanbul Faculty of Medicine Pediatric Hematology-Oncology
Lido
1263
Vezesque se leu este artigo
530
Total PDF
733
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 11 | 22 | 5 | 27 |
| 2025 10 | 70 | 15 | 85 |
| 2025 9 | 56 | 24 | 80 |
| 2025 8 | 37 | 25 | 62 |
| 2025 7 | 43 | 32 | 75 |
| 2025 6 | 34 | 20 | 54 |
| 2025 5 | 40 | 13 | 53 |
| 2025 4 | 30 | 13 | 43 |
| 2025 3 | 33 | 10 | 43 |
| 2025 2 | 32 | 27 | 59 |
| 2025 1 | 24 | 18 | 42 |
| 2024 12 | 13 | 17 | 30 |
| 2024 11 | 25 | 18 | 43 |
| 2024 10 | 19 | 28 | 47 |
| 2024 9 | 20 | 19 | 39 |
| 2024 8 | 24 | 20 | 44 |
| 2024 7 | 19 | 19 | 38 |
| 2024 6 | 30 | 25 | 55 |
| 2024 5 | 57 | 27 | 84 |
| 2024 4 | 19 | 12 | 31 |
| 2024 3 | 15 | 22 | 37 |
| 2024 2 | 17 | 31 | 48 |
| 2024 1 | 14 | 16 | 30 |
| 2023 12 | 11 | 17 | 28 |
| 2023 11 | 15 | 30 | 45 |
| 2023 10 | 14 | 27 | 41 |
Mostrar tudo
